Delivery Order SPE2DB20D3103-SPE2DB25FM9Y9

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tretinoin 0.05% gel 45 gm. The contract has a ceiling value of $3,336.84 and is structured as a Delivery Order with a Firm Fixed Price pricing type. The contract does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award is for the delivery of Tretinoin Gel Micro 0.04% in 45 gram tubes to the Defense Logistics Agency (DLA). The $2,264.91 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of April 18, 2023 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,619.42 Firm Fixed Price Delivery Order is for the supply of 0.1% Tretinoin Cream, a pharmaceutical product used for various medical conditions. The contract has an ultimate completion date of August 1, 2023 and was awarded on July 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,092.52, is for the delivery of TRETINOIN 0.025% CREAM 20GM, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of September 22, 2023. No set-aside was used for this award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp for the supply of TRETINOIN 0.01% GEL 15GM. The firm-fixed-price delivery order, valued at $1,213.15, was issued under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical that has a ceiling value of up to $999,999,999 through December 2025. The contract does not have a set-aside designation and is intended to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,976.59 Firm Fixed Price Delivery Order covers the supply of Tretinoin 0.05% Cream, 45 grams, a pharmaceutical product. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tretinoin 0.05% Cream 45GM. The $1,018.44 firm fixed-price contract is a delivery order under the company's existing $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,331.30, is a Delivery Order for the delivery of 4563095882 - Tretinoin 0.025% Cream, 45GM. The contract has a completion date of December 14, 2023 and is a Firm Fixed Price contract type. Amerisourcebergen is an established vendor for the DLA, holding a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tretinoin 0.05% Cream in 45-gram units. The $1,216.78 Firm Fixed Price Delivery Order has a period of performance through November 25, 2024. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there are no details provided about any subcontractors. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,429.00 firm-fixed-price delivery order is for the supply of 45-gram tubes of 0.1% Tretinoin cream, a topical retinoid medication. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. This order is a part of AmerisourceBergen's larger...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM9Y9
    Delivery Order

This federal contract award, valued at $2,482.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRETINOIN GEL MICRO 0.04% TUBE 20GM, a pharmaceutical product, and does not have a set-aside designation.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 6/9/25, 9:50 AM